Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal Function

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 8, 2021

Primary Completion Date

August 16, 2022

Study Completion Date

August 16, 2022

Conditions

Renal ImpairmentRenal Disease

Interventions

DRUG

Venetoclax

Oral Tablet

Trial Locations (2)

Orlando Clinical Research Ctr /ID# 224922, Orlando

Acpru /Id# 243398, Grayslake